Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Personalized Medicine for Cancer | Sep 2011 | £315 | 100% |
| Personalized Medicine | Aug 2007 | £1,265 | 99% |
| Personalized Medicine Market Analysis | Jan 2012 | £760 | 99% |
| Thinking Forward A Revolutionary Model That Delivers Value and Market Opportunity for Personalized Medicines |
Jul 2008 | £950 | 98% |
| Business Strategy: Personalized Medicine Looking Forward | Dec 2009 | £2,845 | 98% |
| Perspective: Genomic Complexity and Its Role in Personalizing Medicine More than Just Genes |
Feb 2011 | £950 | 98% |
| Expanding Applications of Personalized Medicine Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach |
Aug 2009 | £2,425 | 98% |
| Cancer Personalized Medicine 2008 | Jul 2008 | £2,425 | 97% |
| Personalized Medicine 2010 Assessing the Opportunities and Challenges in Commercializing Companion |
May 2010 | £1,580 | 97% |
| Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players) |
Apr 2009 | £2,215 | 97% |
| Opportunity for the Obama Economic Stimulus Bill to Accelerate Personalized Medicine, The | Mar 2009 | £950 | 97% |
| MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report | Jul 2009 | £1,800 | 97% |
| Personalized Medicine Market Worldwide (2010 – 2015) By Segments, Technologies, Opportunities, Challenges & Future Forecast |
Feb 2011 | £695 | 97% |
| Personalized Medicine Market Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics |
Dec 2010 | £2,215 | 96% |
| Worldwide Personalized Medicine Market Enabling Equipment, Tools, Technologies, Players Drugs, Opportunities & Market Outlook |
Aug 2010 | £1,450 | 96% |
| Stakeholder Opinions: Biomarkers in Rheumatology Awaiting the next step towards personalized medicine |
Dec 2009 | £2,405 | 96% |
| Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) |
Jun 2008 | £1,895 | 95% |
| Companion Diagnostics in Personalized Medicine and Cancer Therapy | Jul 2011 | £2,150 | 95% |
| Drugs for the Diseases of Aging US Markets and Trends for Prescription Medicines Used Predominantly by Persons Age 50 and older |
Oct 2011 | £1,450 | 94% |
| Personalized Medicine Partnering Terms and Agreements 3rd Edition |
Feb 2012 | £3,160 | 94% |
| Personalized Medicine: Technologies and the Global Market | Jul 2009 | £3,065 | 94% |
| Pipeline Insight: Colorectal Cancer Growing trend towards personalized medicine |
Oct 2009 | £7,210 | 93% |
| The Future of Molecular Diagnostics Innovative Technologies Driving Market Opportunities in Personalized Medicine |
Jun 2010 | £2,425 | 93% |
| Personalized Medicine (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 92% |
| Biomarker Technology Platforms for Cancer Diagnoses and Therapies | Sep 2011 | £2,150 | 90% |
| Commercializing Biomarkers in Therapeutic and Diagnostic Applications | May 2011 | £2,020 | 88% |
| Wellness Market Opportunities in the Aging American Population Alternative Medicine Markets for Age-Related Health Issues |
Sep 2001 | £2,215 | 88% |
| Personal Therapy Sensory Devices Americans Get Their Electronic Om On |
Aug 2007 | £1,260 | 87% |
| Cytogenetics Technologies, Markets and Companies |
Jan 2012 | £1,620 | 85% |
| Biochips/Microarrays Technologies, Markets and Companies |
Jan 2012 | £1,555 | 85% |
